Melanie Ott, MD, PhD
Senior Investigator, Gladstone Institute of Virology and Immunology
Professor, Medicine, University of California, San Francisco
Recorded: Wednesday, April 29nd
Join Melanie Ott, live Wednesday, April 29th, as she shares her perspective on how to think about, deal with, and potentially treat the COVID-19 pandemic.
Melanie is a senior investigator at the Gladstone Institute of Virology and Immunology and a Professor of Medicine at UCSF. She got her MD at the University of Frankfurt/Main and her PhD in molecular medicine from the Picowar Graduate School. Before establishing her lab at the Gladstone, she ran a research group at the German Cancer Research Group.
The Ott lab has focused mostly on HIV and Hepatitis C. Following the breakout of COVID-19, Melanie quickly established a Biosafety Level 3 lab at Gladstone and is working with Dr. Jennifer Doudna to develop a CRISPR-based COVID-19 diagnostic assay. As part of an international effort, Melanie is researching how SARS-CoV-2 attacks lung tissue and which potential drugs might counter the effects.
“I’m originally a neurologist but switched to virology in the ’90s during the AIDS crisis.
I was in Frankfurt. It was very similar to now — there were not treatments available, many people infected and terminally sick. So I decided I wanted to dig deeper into the virus and learn more and maybe make a difference.”
–Melanie Ott in conversation with STAT News
Help shape the upcoming conversation.
In his session, Dr. Melanie Ott will respond to the questions registered attendees sent in through this page, in the live discussion and social media.